Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway

scientific article published on 10 May 2016

Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/JPET.116.232660
P932PMC publication ID4906989
P698PubMed publication ID27347041

P2093author name stringSuwei Wang
Chuan Chen
Jin Zheng
Lina Zhang
Zhihua Yu
Lihe Guo
T E Liu
P2860cites workPremature ovarian failureQ21203021
KNIME-CDK: Workflow-driven cheminformaticsQ21284307
Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin GQ24649515
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)Q27654722
Organic anion transporters and their implications in pharmacotherapy.Q27687273
The organic anion transporter (OAT) family: a systems biology perspectiveQ28085671
Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitroQ28534904
Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence MotifsQ28550639
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidneyQ28592258
Biodiversity mapping in a tropical West African forest with airborne hyperspectral dataQ30391458
Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anionsQ33263153
Interaction of organic cations with organic anion transportersQ33500929
Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacinQ33658156
Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse modelQ33788862
NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB.Q33808220
P-glycoprotein substrate models using support vector machines based on a comprehensive data set.Q33908941
Curcumin induces cell death in esophageal cancer cells through modulating Notch signalingQ34170044
Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living Ames dwarf miceQ34229672
Binding modes and pharmacophore modelling of thermolysin inhibitorsQ34269721
Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transportersQ34309854
Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.Q34335909
Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permeaseQ45232114
Accept/decline decision module for the liver simulated allocation model.Q45956351
Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics.Q46096113
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.Q46312451
Random forest: a classification and regression tool for compound classification and QSAR modelingQ47370701
Effect of atorvastatin on expression of TLR4 and NF-κB p65 in atherosclerotic rabbits.Q50957248
Germ cell deficient (gcd) mouse as a model of premature ovarian failureQ72927688
Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failureQ73476652
???Q27021862
Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterizationQ34413813
Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handlingQ34452514
Predicting substrates of the human breast cancer resistance protein using a support vector machine methodQ34668324
Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failureQ34708642
Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesisQ34865706
The jagged-2/notch-1/hes-1 pathway is involved in intestinal epithelium regeneration after intestinal ischemia-reperfusion injuryQ35009336
Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties.Q35093836
Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysisQ35213248
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).Q35446350
ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failureQ35744778
Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2.Q35979992
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.Q35993954
Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug TransportersQ36250282
Shared Ligands Between Organic Anion Transporters (OAT1 and OAT6) and Odorant ReceptorsQ36316477
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissueQ36665822
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discriminationQ36704152
Organic anion transporter 3 contributes to the regulation of blood pressureQ36842435
Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissuesQ36891909
Growth hormone is a cellular senescence target in pituitary and nonpituitary cellsQ37143459
Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathwaysQ37193094
Premature ovarian "failure" in the adolescentQ37198427
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathwayQ37232979
Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family membersQ37265749
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesisQ37314370
Growth hormone prevents the development of autoimmune diabetesQ37353083
Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indicationsQ37619460
Genes involved in human premature ovarian failure.Q37776380
The SLC22 family with transporters of organic cations, anions and zwitterionsQ38090782
Computational modeling to predict the functions and impact of drug transporters.Q38715008
Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cellsQ39375782
Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion.Q39624984
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family membersQ41905911
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).Q41982492
A novel homologous model for gene therapy of dwarfism by non-viral transfer of the mouse growth hormone gene into immunocompetent dwarf mice.Q42235867
Galactose toxicity in the rat as a model for premature ovarian failure: an experimental approach readdressedQ44595219
Cytogenetic analysis of 179 Iranian women with premature ovarian failureQ45228362
P433issue1
P921main subjectpremature ovarian failureQ647630
P304page(s)215-221
P577publication date2016-05-10
P1433published inExperimental and Therapeutic MedicineQ23979083
P1476titleGrowth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway
P478volume12

Reverse relations

cites work (P2860)
Q92715730Cytochrome P450 family proteins as potential biomarkers for ovarian granulosa cell damage in mice with premature ovarian failure
Q60923928Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time
Q41404165Glucocorticoids regulate the proliferation of T cells via miRNA-155 in septic shock
Q98164459High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
Q38685365Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
Q90441623Long non-coding RNA HOTAIR overexpression improves premature ovarian failure by upregulating Notch-1 expression
Q57176854Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
Q92087896NOTCH2 variant D1853H is mutated in two non-syndromic premature ovarian insufficiency patients from a Chinese pedigree
Q41845623Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes.
Q39140289Renal Drug Transporters and Drug Interactions
Q92404219The Role of Growth Hormone on Ovarian Functioning and Ovarian Angiogenesis
Q89971043The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology
Q38648038The drug transporter OAT3 (SLC22A8) regulates endogenous metabolite flow through the gut-liver-kidney axis
Q39017932The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters.
Q51102882Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition.
Q91387197Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling

Search more.